The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index.
Neuroprotection by Histone Deacetylase-Related Protein
Abstract
The expression of histone deacetylase-related protein (HDRP) is reduced in neurons undergoing apoptosis. Forced reduction of HDRP expression in healthy neurons by treatment with antisense oligonucleotides also induces cell death. Likewise, neurons cultured from mice lacking HDRP are more vulnerable to cell death. Adenovirally mediated expression of HDRP prevents neuronal death, showing that HDRP is a neuroprotective protein. Neuroprotection by forced expression of HDRP is not accompanied by activation of the phosphatidylinositol 3-kinase-Akt or Raf-MEK-ERK signaling pathway, and treatment with pharmacological inhibitors of these pathways fails to inhibit the neuroprotection by HDRP. Stimulation of c-Jun phosphorylation and expression, an essential feature of neuronal death, is prevented by HDRP. We found that HDRP associates with c-Jun N-terminal kinase (JNK) and inhibits its activity, thus explaining the inhibition of c-Jun phosphorylation by HDRP. HDRP also interacts with histone deacetylase 1 (HDAC1) and recruits it to the c-Jun gene promoter, resulting in an inhibition of histone H3 acetylation at the c-Jun promoter. Although HDRP lacks intrinsic deacetylase activity, treatment with pharmacological inhibitors of histone deacetylases induces apoptosis even in the presence of ectopically expressed HDRP, underscoring the importance of c-Jun promoter deacetylation by HDRP-HDAC1 in HDRP-mediated neuroprotection. Our results suggest that neuroprotection by HDRP is mediated by the inhibition of c-Jun through its interaction with JNK and HDAC1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC inhibitors also demonstrate anti-inflammatory and neuroprotective effects in neurodegenerative models by dampening inflammatory signaling and supporting synaptic and cognitive function (Morrison et al., 2006; Zhou et al., 2018; Kumar et al., 2022).”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Morrison et al., 2006
Citations
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., RAKIC, P. T., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,230
Brunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,208
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,051
Self-citationD'Mello, S. R., Galli, C., Ciotti, T., & Calissano, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10989 · Cited by 892
Self-citationHockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi‐Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 847
A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death
Ham, J., Babij, C., Whitfield, J. R., Pfarr, C. M., Lallemand, D., Yaniv, M., & Rubin, L. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90331-3 · Cited by 795
Ferrante, R. J., Kubilus, J. K., Lee, J.-H., Ryu, H., Beesen, A. A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi‐Carter, R., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 705
Class II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501497 · Cited by 526
Self-citationLu, J., McKinsey, T. A., Nicol, R. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080064097 · Cited by 518
Self-citationHistone Deacetylase Inhibitors
Marks, P. A., Richon, V. M., Miller, T., & Kelly, W. K. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)91004-4 · Cited by 432
Watson, A., Eilers, A., Lallemand, D., Kyriakis, J. M., Rubin, L. L., & Ham, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00751.1998 · Cited by 360
Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration
Rouaux, C., Jokic, N., Mbebi, C., Boutillier, S., Loeffler, J., & Boutillier, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg615 · Cited by 302
Role of extracellular signal regulated kinases 1 and 2 in neuronal survival
Hetman, M., & Góźdź, A. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04133.x · Cited by 274
Ryu, H., Lee, J.-H., Olofsson, B. A., Mwidau, A., Deodoglu, A., Escudero, M., Flemington, E. K., Azizkhan‐Clifford, J., Ferrante, R. J., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737363100 · Cited by 262
Regulating histone acetyltransferases and deacetylases
Legube, G., & Trouche, D. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor941 · Cited by 261
c-Jun and the transcriptional control of neuronal apoptosis
Ham, J., Eilers, A., Whitfield, J. R., Neame, S. J., & Shah, B. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00372-5 · Cited by 242
Johnson, D., Horsley, S. W., Moloney, D. M., Oldridge, M., Twigg, S. R. F., Walsh, S., Barrow, M., Njølstad, P. R., Kunz, J., Ashworth, G. J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302122 · Cited by 230
MEF‐2 function is modified by a novel co‐repressor, MITR
Sparrow, D. B., Miska, E. A., Langley, E., Reynaud‐Deonauth, S., Kotecha, S., Towers, N., Spohr, G., Kouzarides, T., & Mohun, T. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5085 · Cited by 196
Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell Death
Bolger, T. A., & Yao, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1826-05.2005 · Cited by 190
Coffey, E. T., Smiciene, G., Hongisto, V., Cao, J., Brecht, S., Herdegen, T., & Courtney, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04335.2002 · Cited by 184
Lukiw, W. J., & Bazan, N. G. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5 · Cited by 182
Self-citationLangley, B. C., Gensert, J. M., Beal, M. F., & Ratan, R. R. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007053005091 · Cited by 169
The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms
Petrie, K. R., Guidez, F., Howell, L., Healy, L. E., Waxman, S., Greaves, M. F., & Zelent, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212935200 · Cited by 147
Mixed-Lineage Kinases: A Target for the Prevention of Neurodegeneration
Wang, L. H., Besirli, C. G., & Johnson, E. M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121840 · Cited by 145
Sée, V., Boutillier, A., Bito, H., & Loeffler, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0106com · Cited by 138
Targeting JNK3 for the treatment of neurodegenerative disorders
Resnick, L., & Fennell, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03251-9 · Cited by 128
Linseman, D. A., Bartley, C. M., Le, S. S., Laessig, T. A., Bouchard, R. J., Meintzer, M. K., Li, M., & Heidenreich, K. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307245200 · Cited by 124
Zhou, X., Richon, V. M., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1056 · Cited by 120
The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis
Zhang, C. L., McKinsey, T. A., & Olson, E. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131198498 · Cited by 118
Self-citationNeuronal apoptosis induced by histone deacetylase inhibitors
Salminen, A., Tapiola, T., Korhonen, P., & Suuronen, T. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00210-1 · Cited by 109
Hack, N., Hidaka, H., Wakefield, M. J., & Balázs, R. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90108-r · Cited by 103
Targeting the JNK Signaling Pathway for Stroke and Parkinsons Diseases Therapy
Kuan, C.-Y., & Burke, R. E. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007053005145 · Cited by 100
Koulich, E., Nguyen, T. N., Johnson, K., Giardina, C. A., & D’Mello, S. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00134.x · Cited by 98
Self-citationPhenotypic findings due to trisomy 7p15.3-pter including theTWIST locus
Stankiewicz, P., Thiele, H., Baldermann, C., Kr�ger, A., Giannakudis, I., D�rr, S., Werner, N., Kunz, J., Rappold, G. A., & Hansmann, I. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1512 · Cited by 97
Diversity in the Sir2 family of protein deacetylases
Buck, S. W., Gallo, C. M., & Smith, J. S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0903424 · Cited by 97
Boutillier, A., Trinh, E., & Loeffler, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01581.x · Cited by 94
Chin, P. C., Liu, L., Morrison, B. E., Siddiq, A., Ratan, R. R., Bottiglieri, T., & D’Mello, S. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02530.x · Cited by 93
Self-citationKoulich, E., Nguyen, T. N., Johnson, K., Giardina, C. A., & D’Mello, S. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00303.x · Cited by 76
Self-citationTargeting the JNK Pathway for Therapeutic Benefit in CNS Disease
Bozyczko‐Coyne, D., Saporito, M. S., & Hudkins, R. L. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339472 · Cited by 68
Graczyk, P. P., Khan, A., Bhatia, G. S., Palmer, V. H., Medland, D., Numata, H., Oinuma, H., Catchick, J., Dunne, A., Ellis, M. V., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.076 · Cited by 56
Keramaris, E., Vanderluit, J. L., Bahadori, M. H., Mousavi, K., Davis, R. J., Flavell, R. A., Slack, R. S., & Park, D. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410127200 · Cited by 42
Yalcin, A., Koulich, E., Mohamed, S. A., Liu, L., & D’Mello, S. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01540.x · Cited by 40
Self-citationLoss of heterozygosity at 7p in Wilms’ tumour development
Powlesland, R. M., CHARLES, A. K., Malik, K. T. A., Reynolds, P. A., Pires, S., Boavida, M. G., & Brown, K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0922 · Cited by 38
Schmidt, H., Taubert, H. W., Würl, P., Kappler, M., Lange, H., Bartel, F., Bache, M., Holzhausen, H. ‐., & Hinze, R. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10036 · Cited by 32
Boutillier, A., Trinh, E., & Loeffler, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04679.x · Cited by 28
Lewanda, A. F., Green, E. D., Weissenbach, J., Jerald, H., Taylor, E. W., Summar, M. L., Phillips, J. A., COHEN, M. P., Feingold, M., & Mouradian, W. E. (1994) · PubMed Central · Cited by 22
Borrás, E., Zaragozá, R., Morante, M., Garcı́a, C., Gimeno, A., López‐Rodas, G., Barber, T., Miralles, V. J., Vinã, J. R., & Torres, L. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03511.x · Cited by 19
Flagged first, then by citations
2 of the 51 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Lewanda A. F., 1994, Am. J. Hum. Genet., 55, 1195
Cited by
Sorted by citations
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 727
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Nand, S., Dilnashin, H., Birla, H., Singh, S. S., Zahra, W., Singh, B. K., Singh, S. P., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0003-y · Cited by 490
Epigenetic regulation of gene expression in physiological and pathological brain processes
Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373
Targeting the correct HDAC(s) to treat cognitive disorders
Fischer, A., Sananbenesi, F., Mungenast, A. E., & Tsai, L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.003 · Cited by 365
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Kim, D., Frank, C. L., Dobbin, M. M., Tsunemoto, R. K., Tu, W., Peng, P. L., Guan, J.-S., Lee, B.-H., Moy, L. Y., Giusti, P., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.015 · Cited by 286
Metadata
- Authors
- Morrison, B. E., Majdzadeh, N., Zhang, X., Lyles, A., Bassel-Duby, R., Olson, E. N., & D'Mello, S. R.
- Affiliations
- The University of Texas at Dallas (US)
- Department of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390
- The University of Texas Southwestern Medical Center (US)
- Department of Molecular and Cell Biology, University of Texas at Dallas, 2601 N. Floyd Rd., Richardson, Texas 75083
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-05-01
- Volume
- 26
- Issue
- 9
- Pages
- 3550-3564
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2024126284
- Cited by
- 100
- References
- 51
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 2 · 2015: 8 · 2014: 6 · 2013: 7 · 2012: 7
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (NS047201, R01NS040408, NS40408, R01NS047201)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- neuroprotection, neuronal apoptosis, c-Jun phosphorylation, c-Jun N-terminal kinase, HDAC1, histone H3 acetylation, c-jun promoter, phosphatidylinositol 3-kinase/Akt signaling, MAPK/ERK pathway, antisense oligonucleotides, adenoviral gene expression, histone deacetylase inhibitors
- MeSH terms
- Phosphoinositide-3 Kinase Inhibitors, Animals, Cell Nucleus, Enzyme Inhibitors, Histone Deacetylases, Neurons, Phosphorylation, RNA, Messenger, Transcription, Genetic, Proto-Oncogene Proteins c-jun, Apoptosis, Phosphatidylinositol 3-Kinases, JNK Mitogen-Activated Protein Kinases, Extracellular Signal-Regulated MAP Kinases, Mice, Rats, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review